Proliferation Biomarkers in Drug Discovery and Development - The Immunoassay of Thymidine Kinase 1

Explore the role of proliferation biomarkers in drug discovery and development, with a focus on the immunoassay of Thymidine Kinase 1 (TK1) in this 27-minute webinar presented by Martin Shaw, an expert in laboratory medicine and biomarker industries. Learn how proliferation biomarkers, particularly TK1, can provide valuable insights into tumor aggressivity and potential therapeutic responses. Discover the unique advantages of TK1 as a measurable biomarker in body fluids, making it convenient for monitoring cell proliferation. Gain understanding of the limitations of previous enzymatic activity-based assays and how new immunoassay techniques can improve TK1 detection, especially in solid tumors like prostate and breast cancer. Enhance your knowledge of biomarker applications in oncology research and drug development through this informative presentation.

Proliferation Biomarkers in Drug Discovery and Development, The Immunoassay of Thymidine Kinase 1